1. Liquid Biopsy Analysis as a Tool for TKI-Based Treatment in Non-Small Cell Lung Cancer
    Karolina Buszka et al, 2022, Cells CrossRef
  2. The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments
    Daniel Di Capua et al, 2021, Cancers CrossRef
  3. Double-Stranded DNA in Exosomes of Malignant Pleural Effusions as a Novel DNA Source for EGFR Mutation Detection in Lung Adenocarcinoma
    Xueling Qu et al, 2019, Frontiers in Oncology CrossRef
  4. Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer
    Eva Obermayr et al, 2021, Journal of Personalized Medicine CrossRef
  5. Circulating EGFR Mutations in Patients with Lung Adenocarcinoma by Circulating Tumor Cell Isolation Systems: A Concordance Study
    Shih-Hong Li et al, 2022, International Journal of Molecular Sciences CrossRef
  6. Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges
    Erika Rijavec et al, 2019, Cancers CrossRef
  7. Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
    Connor O’Leary et al, 2020, Pharmaceuticals CrossRef